Search results for "eosinophilic myeloproliferative disorder"

The MalaCard for "eosinophilic myeloproliferative disorder" has been retired.
Searching MalaCards for entries containing "eosinophilic myeloproliferative disorder"

188 hits were found for 'eosinophilic myeloproliferative disorder'

# Family MCID Name MIFTS Score
1
MYL015 Myeloproliferative Disorder with Eosinophilia 35 6.258
2
PDG002 Pdgfrb-Associated Chronic Eosinophilic Leukemia 17 4.238
3
P LKM002 Leukemia 70 0.429
4
P ESP024 Esophagitis 62 0.375
5
P ESN007 Eosinophilia 61 0.325
6
P AST005 Asthma 82 0.305
7
CMP005 Campomelic Dysplasia 72 0.250
8
P MYL005 Myelofibrosis 67 0.218
9
TNP003 Tn Polyagglutination Syndrome, Somatic 44 0.214
10
P HYP098 Hypereosinophilic Syndrome 51 0.214
11
P MNN013 Meningitis 65 0.213
12
LKC003 Leukocyte Disease 47 0.211
13
P MYL006 Myeloid Leukemia 67 0.208
14
P LYM118 Lymphoma 70 0.207
15
BNM001 Bone Marrow Cancer 52 0.206
16
ESN006 Eosinophilic Meningitis 32 0.205
17
MYL009 Myelodysplastic Syndrome 74 0.204
18
THR004 Thrombocytosis 55 0.201
19
DWN001 Down Syndrome 65 0.200
20
MRG013 Mirage Syndrome 26 0.197
21
P PLY018 Polycythemia 57 0.184
22
CHR563 Chronic Eosinophilic Leukemia 47 0.180
23
WLL006 Wells Syndrome 56 0.177
24
END072 Endotheliitis 42 0.174
25
BNS002 Bone Structure Disease 36 0.169
26
BNC003 Bone Cancer 45 0.164
27
MYL004 Myelodysplastic Myeloproliferative Cancer 47 0.160
28
c ACT073 Acute Leukemia 62 0.155
29
P HPT021 Hepatitis 70 0.153
30
HMT002 Hematologic Cancer 64 0.152
31
DRM006 Dermatitis 61 0.152
32
CHR285 Chronic Myelomonocytic Leukemia 55 0.148
33
GST078 Gastrointestinal Allergy 41 0.144
34
PLY125 Polycythemia Vera, Somatic 63 0.141
35
c CHR418 Chronic Leukemia 48 0.138
36
P ATP001 Atopic Dermatitis 62 0.137
37
ACD009 Acid-Labile Subunit, Deficiency of 48 0.133
38
c MCL062 Mucolipidosis Ii Alpha/beta 60 0.129
39
BLD053 Blood Platelet Disease 46 0.129
40
PHY002 Physical Disorder 44 0.128
41
ALL026 Allergic Hypersensitivity Disease 53 0.127
42
c LKM061 Leukemia, Acute Myeloid 71 0.127
43
VSC011 Vasculitis 62 0.127
44
P MST009 Mastocytosis 54 0.126
45
LRN003 Learning Disability 51 0.123
46
CHL071 Child Syndrome 58 0.121
47
ALR002 Al-Raqad Syndrome 36 0.120
48
KDS001 Kid Syndrome 53 0.120
49
DRG012 Drug Rash with Eosinophilia and Systemic Symptoms 35 0.119
50
P LYM026 Lymphoblastic Leukemia 60 0.118
51
ADL002 Adult Syndrome 53 0.117
52
ATN002 Autonomic Nervous System Disease 47 0.116
53
CRB009 Cerebritis 38 0.115
54
ACT193 Acute Myeloid Leukemia with Abnormal Bone Marrow Eosinophils Inv(16)(p13q22) or T(16;16)(p13;q22) 48 0.115
55
ALN001 Aland Island Eye Disease 45 0.113
56
CSY001 C Syndrome 49 0.113
57
P MYS005 Myositis 56 0.112
58
c AST039 Asthma 2 31 0.112
59
BLD054 Blood Protein Disease 40 0.107
60
DSS003 Disseminated Eosinophilic Collagen Disease 18 0.106
61
PDG001 Pdgfra-Associated Chronic Eosinophilic Leukemia 15 0.106
62
PLM035 Pulmonary Eosinophilia 46 0.104
63
MTH009 Mouth Disease 63 0.103
64
c SYS004 Systemic Mastocytosis 59 0.103
65
LNG099 Lung Disease 62 0.099
66
LYM040 Lymphoblastic Lymphoma 54 0.099
67
P HRT032 Heart Disease 76 0.095
68
CNN005 Connective Tissue Disease 61 0.095
69
c PRM149 Primary Hypereosinophilic Syndrome 39 0.091
70
P LYM033 Lymphoproliferative Syndrome 53 0.091
71
P PRP019 Peripheral Nervous System Disease 54 0.091
72
P MYP004 Myopathy 67 0.090
73
P SPS003 Spastic Diplegia 53 0.090
74
BRT030 Birth Defects 43 0.090
75
ACR041 Acromelic Frontonasal Dysostosis 46 0.090
76
HMT018 Hematopoietic Stem Cell Transplantation 41 0.088
77
PHY001 Physiological Polycythemia 31 0.088
78
LYM024 Lymphatic System Disease 50 0.088
79
SRC014 Sarcoma 66 0.088
80
RFR010 Refractory Anemia 45 0.088
81
P ENC018 Encephalopathy 59 0.085
82
WTH001 Withdrawal Disorder 41 0.084
83
MYL052 Myeloproliferative Neoplasms, Familial 17 0.084
84
IMM127 Immune System Cancer 42 0.083
85
ADJ001 Adjustment Disorder 38 0.082
86
SPL018 Splenomegaly 44 0.082
87
PRT036 Peritonitis 62 0.080
88
P AXN010 Axenfeld-Rieger Syndrome, Type 3 54 0.079
89
SKN016 Skin Disease 68 0.079
90
GRF001 Graft-Versus-Host Disease, Protection Against 54 0.078
91
P CRD011 Cardiomyopathy 67 0.078
92
c FBR046 Fibrosis of Extraocular Muscles, Congenital, 1 41 0.075
93
P MSC033 Muscle Disorders 52 0.073
94
PRD011 Proud Syndrome 42 0.073
95
P HML002 Hemolytic Anemia 60 0.073
96
PNN001 Panniculitis 50 0.073
97
c LYM107 Lymphoproliferative Syndrome 2 34 0.072
98
P ACT135 Acute Graft Versus Host Disease 53 0.072
99
SPC003 Specific Developmental Disorder 40 0.072
100
P PRT013 Portal Hypertension 59 0.072
101
OCL009 Ocular Cancer 62 0.071
102
c SCN042 Secondary Hypereosinophilic Syndrome 16 0.071
103
P PRX003 Paroxysmal Nocturnal Hemoglobinuria 60 0.071
104
HRT007 Heart Cancer 50 0.071
105
c CHR417 Chronic Graft Versus Host Disease 50 0.070
106
P THR014 Thrombocytopenia 64 0.070
107
P HRT017 Heart Tumor 35 0.070
108
c CRN214 Coronary Heart Disease 5 23 0.070
109
P MNC007 Monocytic Leukemia 55 0.070
110
MST017 Mast Cell Disease 52 0.070
111
c ADL079 Adult Heart Tumor 19 0.070
112
P PLM036 Pulmonary Fibrosis 68 0.069
113
TBR010 Tuberculosis 69 0.069
114
SKN023 Skin Tag 46 0.069
115
HMG002 Hemoglobinuria 49 0.069
116
UPP004 Upper Respiratory Tract Disease 48 0.068
117
P PSR002 Psoriasis 63 0.067
118
P LVR013 Liver Disease 72 0.067
119
P BRS047 Breast Cancer 100 0.067
120
HDG012 Hodgkin Lymphoma 73 0.067
121
MSC004 Muscle Tissue Disease 36 0.066
122
P SHR029 Short Syndrome 60 0.066
123
ART111 Artery Disease 57 0.065
124
ORL011 Oral Cancer 55 0.065
125
NTR005 Nutritional Deficiency Disease 39 0.065
126
P PLY041 Polymyositis 51 0.064
127
WSC001 Wisconsin Syndrome 17 0.063
128
P TCL004 T-Cell Leukemia 46 0.063
129
c LYM106 Lymphoproliferative Syndrome 1 34 0.063
130
VND001 Vein Disease 52 0.062
131
P NRV006 Nervous System Cancer 62 0.062
132
c ADL001 Adult Lymphoma 41 0.062
133
PRN039 Paraneoplastic Syndromes 33 0.062
134
WST001 West Syndrome 61 0.062
135
ACT200 Acute Monoblastic Leukemia 44 0.062
136
P APL001 Aplastic Anemia 73 0.062
137
LYM019 Lymphosarcoma 53 0.062
138
c ACT009 Acute Monocytic Leukemia 52 0.061
139
P MLT019 Multiple Myeloma 80 0.061
140
GLC077 Glucocorticoid Therapy, Response to 19 0.060
141
HYP266 Hypoxia 55 0.059
142
P HYP071 Hypersensitivity Reaction Type Ii Disease 51 0.059
143
P CRN211 Coronary Artery Disease 75 0.059
144
c ATM010 Autoimmune Hemolytic Anemia 60 0.058
145
P SPN301 Spinocerebellar Ataxia 2 63 0.056
146
c TRC078 Trichohepatoenteric Syndrome 2 31 0.056
147
c RNL016 Renal Infectious Disease 24 0.055
148
PRC012 Pericardial Effusion 50 0.055
149
c CRN173 Coronary Heart Disease 8 20 0.055
150
HRT029 Heart Tumor of the Child 17 0.055
151
NTR018 Neutrophilia, Hereditary 45 0.053
152
ISC004 Ischemia 59 0.053
153
c CNN010 Connective Tissue Benign Neoplasm 35 0.053
154
c NRF018 Neurofibromatosis, Type 1 68 0.051
155
c ADL017 Adult T-Cell Leukemia 58 0.051
156
P MSC005 Muscular Dystrophy 64 0.051
157
FML039 Female Reproductive System Disease 48 0.050
158
PRM025 Primary Bacterial Infectious Disease 43 0.050
159
MYL003 Myeloid Sarcoma 48 0.050
160
ACT177 Acute Basophilic Leukemia 34 0.049
161
PRT011 Protein C Deficiency 51 0.049
162
c DLT002 Dilated Cardiomyopathy 75 0.049
163
PRP036 Peripheral T-Cell Lymphoma 45 0.048
164
CNG034 Congestive Heart Failure 71 0.048
165
PRP027 Peripheral Vascular Disease 69 0.047
166
PYD001 Pyoderma Gangrenosum 49 0.046
167
PYD002 Pyoderma 49 0.046
168
P HNT016 Huntington Disease 80 0.046
169
c ESN023 Eosinophilia, Familial 19 0.046
170
MYL013 Myeloperoxidase Deficiency 46 0.045
171
NVS004 Nova Syndrome 19 0.045
172
GLC037 Glucocorticoid Resistance 62 0.044
173
P HMR012 Hemorrhagic Fever 55 0.043
174
BLD044 Bladder Disease 51 0.043
175
P EXN002 Exanthem 57 0.042
176
c THR092 Thrombophilia Due to Thrombin Defect 56 0.041
177
ACT058 Active Peptic Ulcer Disease 46 0.041
178
CRY005 Cryptococcosis 50 0.040
179
P GST049 Gastrointestinal System Cancer 60 0.039
180
INT253 Intestinal Benign Neoplasm 50 0.039
181
MNC004 Monoclonal Paraproteinemia 37 0.039
182
DRF001 Dirofilariasis 37 0.039
183
LVR012 Liver Cirrhosis 67 0.038
184
c JVN003 Juvenile Xanthogranuloma 40 0.038
185
BLD087 Bladder Cancer, Somatic 67 0.036
186
HYP319 Hypereosinophilic Syndrome, Idiopathic, Resistant to Imatinib 39 0.036
187
c DLT001 Delta Chain Disease 16 0.035
188
AGG002 Aggressive Systemic Mastocytosis 42 0.035